GlassScriptPhysician profile
Nancy L Silverberg
NPI 1083602023
$1,125.73
in general payments reported to CMS, 2019-2025
19 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $238 · 2021: $97.64 · 2022: $66.30 · 2024: $161 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304 · Travel and Lodging: $3.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.54 |
| Travel and Lodging | $3.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $183.64 | 2019-2021 | |
| Lilly USA, LLC | $161.30 | 2024 | Olumiant |
| Janssen Scientific Affairs, LLC | $145.57 | 2025 | Tremfya |
| Amgen INC. | $97.96 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $86.45 | 2019 | |
| Galderma Laboratories, L.P. | $84.58 | 2019-2022 | |
| Celgene Corporation | $40.45 | 2019 | |
| Biofrontera INC. | $39.78 | 2019 | |
| Abbvie INC. | $37.30 | 2019 | |
| Allergan, INC. | $36.67 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.81 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $28.33 | 2020 | |
| Almirall LLC | $28.21 | 2022 | |
| Vyne Pharmaceuticals INC. | $22.63 | 2020 | |
| Aclaris Therapeutics, INC. | $21.88 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $21.20 | 2020 | |
| Genzyme Corporation | $20.95 | 2020 | |
| Dusa Pharmaceuticals, INC. | $18.77 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Silverberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.